Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis

Table 3 Interleukin-9 association with proinflammatory, angiogenic and Th1 and Th2 subset-specific cytokines

	CD active	CD inactive	UC active	UC inactive	Controls
IL1β	NS	0.58, P = 0.020	0.42, P = 0.002	0.76, P < 0.0001	0.51, P < 0.00011
IL6	NS	0.58, P = 0.018	0.38, P = 0.005	0.77, P < 0.00011	0.33, P < 0.001
IL13	0.48, P < 0.00011	0.62, P = 0.0101	NS	NS	0.46, P < 0.00011
IFNγ	0.29, P = 0.008	NS	0.51, P = 0.00011	0.74, P = 0.0001	NS
TNFα	NS	NS	NS	0.65, P = 0.001	0.19, P = 0.045
VEGFA	0.37, P < 0.0011	0.77, P < 0.0011	0.38, P = 0.006	0.46, P = 0.033	0.36, P = 0.0001

¹Independently associated with IL9 in multivariate analysis (stepwise method). CD: Crohn’s disease; UC: Ulcerative colitis.